The 11th international London cough symposium

Patient insights to shape development of a dCBT for IPF patients

Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients

Untangling the dualistic components of the RAS in PF the Yin and Yang

Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic

C21 shows promise against COVID-19 where other drugs have failed